Steatotic liver disease: Know your enemies
Príomhchruthaitheoir: | Lung-Yi Mak |
---|---|
Formáid: | Alt |
Teanga: | English |
Foilsithe / Cruthaithe: |
Korean Association for the Study of the Liver
2024-04-01
|
Sraith: | Clinical and Molecular Hepatology |
Ábhair: | |
Rochtain ar líne: | http://e-cmh.org/upload/pdf/cmh-2024-0078.pdf |
Míreanna comhchosúla
Míreanna comhchosúla
-
Risk of Hepatocellular Carcinoma by Steatotic Liver Disease and Its Newly Proposed Subclassification
de réir: Byeong Geun Song, et al.
Foilsithe / Cruthaithe: (2024-03-01) -
Pathology and Pathogenesis of Metabolic Dysfunction-Associated Steatotic Liver Disease-Associated Hepatic Tumors
de réir: Yoshihisa Takahashi, et al.
Foilsithe / Cruthaithe: (2023-10-01) -
Pharmacological therapy of metabolic dysfunction-associated steatotic liver disease-driven hepatocellular carcinoma
de réir: Yumin Wang, et al.
Foilsithe / Cruthaithe: (2024-01-01) -
In response to: Steatotic liver disease-know your enemies
de réir: Michael H. Le, et al.
Foilsithe / Cruthaithe: (2024-04-01) -
A Machine Learning Model to Predict Risk for Hepatocellular Carcinoma in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease
de réir: Souvik Sarkar, et al.
Foilsithe / Cruthaithe: (2024-01-01)